Share-based Payment Arrangement, Expense in USD of Predictive Oncology Inc. from 2012 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Predictive Oncology Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2012 to Q3 2025.
  • Predictive Oncology Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $405K.
  • Predictive Oncology Inc. annual Share-based Payment Arrangement, Expense for 2024 was $906.000, a 175% increase from 2023.
  • Predictive Oncology Inc. annual Share-based Payment Arrangement, Expense for 2023 was $330.000, a 99.7% decline from 2022.
  • Predictive Oncology Inc. annual Share-based Payment Arrangement, Expense for 2022 was $109K, a 26% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Predictive Oncology Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $405K +$405K 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q1 2025 $730 $558 -$176 -24% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $906 -$161 +$332 +67.3% 01 Oct 2024 31 Dec 2024 8-K 18 Jul 2025
Q3 2024 $574 $87.00* +$14.4K 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q2 2024 -$13.8K $246* -$5.63K 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025
Q1 2024 -$8.22K $734 -$8.55K -92.1% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2024
Q4 2023 $330 -$493 -$6.2K -109% 01 Oct 2023 31 Dec 2023 8-K 18 Jul 2025
Q3 2023 $6.53K -$14.3K -$41.3K -153% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 $47.9K $5.87K -$33.5K -85.1% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 $81.4K $9.29K -$27.2K -74.6% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q4 2022 $109K $5.7K +$486K 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 -$378K $27K -$2.01K -6.93% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 -$376K $39.4K +$6.14K +18.5% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 -$382K $36.5K -$529K -93.5% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 $147K -$481K -$703K -316% 01 Oct 2021 31 Dec 2021 10-K 21 Mar 2023
Q3 2021 $850K $29K -$106K -78.5% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 $956K $33.2K -$102K -75.4% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 $1.06M $565K +$277K +96.3% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 $780K $223K -$23.2K -9.45% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 $804K $135K -$225K -62.6% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 $1.03M $135K -$1.25M -90.2% 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021
Q1 2020 $2.27M $288K +$24.2K +9.2% 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021
Q4 2019 $2.25M $246K -$78.6K -24.2% 01 Oct 2019 31 Dec 2019 10-K 15 Mar 2021
Q3 2019 $2.33M $360K +$20.2K +5.94% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020
Q2 2019 $2.31M $1.38M +$1.15M +490% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020
Q1 2019 $1.16M $264K +$37.2K +16.4% 01 Jan 2019 31 Mar 2019 10-Q 08 Jun 2020
Q4 2018 $1.12M $325K 01 Oct 2018 31 Dec 2018 10-K 01 Apr 2020
Q3 2018 $340K 01 Jul 2018 30 Sep 2018 10-Q 15 Nov 2019
Q2 2018 $234K 01 Apr 2018 30 Jun 2018 10-Q 19 Aug 2019
Q1 2018 $226K +$127K +128% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q1 2017 $99.3K +$61.5K +163% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q1 2016 $37.8K -$34.3K -47.6% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q1 2015 $72.1K -$187K -72.2% 01 Jan 2015 31 Mar 2015 10-Q 23 May 2016
Q1 2014 $259K -$1.07M -80.5% 01 Jan 2014 31 Mar 2014 10-Q 18 May 2015
Q1 2013 $1.33M 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014

Predictive Oncology Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $906 +$576 +175% 01 Jan 2024 31 Dec 2024 8-K 18 Jul 2025
2023 $330 -$108K -99.7% 01 Jan 2023 31 Dec 2023 8-K 18 Jul 2025
2022 $109K -$38.1K -26% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 $147K -$634K -81.2% 01 Jan 2021 31 Dec 2021 10-K 21 Mar 2023
2020 $780K -$1.47M -65.3% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 $2.25M +$1.13M +100% 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2021
2018 $1.12M -$1.17M -51.1% 01 Jan 2018 31 Dec 2018 10-K 01 Apr 2020
2017 $2.3M +$2.13M +1291% 01 Jan 2017 31 Dec 2017 10-K/A 02 Apr 2019
2016 $165K -$707K -81% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018
2015 $872K +$149K +20.5% 01 Jan 2015 31 Dec 2015 10-K 15 Mar 2017
2014 $723K -$2.98M -80.5% 01 Jan 2014 31 Dec 2014 10-K 16 Mar 2016
2013 $3.7M +$2.87M +346% 01 Jan 2013 31 Dec 2013 10-K 30 Apr 2015
2012 $830K 01 Jan 2012 31 Dec 2012 10-K 27 Mar 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.